학술논문

Randomized Placebo-Controlled and Controlled Non-Inferiority Phase III Trials Comparing Trafermin, a Recombinant Human Fibroblast Growth Factor 2, and Enamel Matrix Derivative in Periodontal Regeneration in Intrabony Defects
Document Type
Article
Source
In: Journal of Bone and Mineral Research. (Journal of Bone and Mineral Research, 1 April 2016, 31(4):806-814)
Subject
Language
English
ISSN
15234681
08840431